Theratechnologies Inc T.TH

Is this a big deal?

[longterm56]

I'm not sure I understand the impact of this article ... does this new data support the use of Egrifta for NASH or is this a completely different use of the drug?  Since Egrifta is already approved, will this allow doctors to prescribe it for additional patients other than Lipo?

Thanks -

  -LT

[scarlet1967]

This is just another finding that explains  other  benefits of Egrifta for patients suffering with NASH. Many HIV patients suffering from Lipodystrophy also have NASH, Dr.Grinspoon has already started  those patients on the drug . So Doctors can if they choose so treat patients for both conditions with Egrifta although the drug is not approved for NASH.

[qwerty22]

I don't think it has direct impact on scripts, although if the general profile of Egrifta is changing with hiv doctors then I suppose maybe. If you're buying the totality of the evidence argument for Egrifta in NASH then it's another important piece for that, inflammation is a big part of the story. If you're trying to construct support for the drug that doesn't have strong